You are here

  • Home
  • Archive
  • Volume 23, Issue 4
  • Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus

Article metrics

Article menu
Download PDFPDF
Original article
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus

 

Online download statistics by month:

Online download statistics by month: December 2015 to March 2024

AbstractFullPdf
Dec 201511205
Jan 20168500
Feb 20163101
Mar 20163100
Apr 20165002
May 20164701
Jun 201618823
Jul 201639406
Aug 201637003
Sep 20164004
Oct 20164700
Nov 20166540
Dec 20163020
Jan 20173924
Feb 201749112
Mar 20174254
Apr 20175730
May 20175210
Jun 20177542
Jul 20178112
Aug 20179021
Sep 201711600
Oct 201713300
Nov 201710202
Dec 201713503
Jan 201813002
Feb 201817210
Mar 201817320
Apr 201814541
May 201817000
Jun 20188401
Jul 201812001
Aug 201812313
Sep 201814901
Oct 20189700
Nov 201812501
Dec 201815600
Jan 201915013
Feb 201916311
Mar 201910221
Apr 20197813
May 201913912
Jun 20195200
Jul 20199123
Aug 20197831
Sep 20193800
Oct 20195511
Nov 20196902
Dec 20197421
Jan 20207711
Feb 20205800
Mar 20206400
Apr 20203900
May 20206532
Jun 20203810
Jul 20203600
Aug 20201820
Sep 20208700
Oct 20205500
Nov 20208000
Dec 20203412
Jan 20213622
Feb 20217100
Mar 20214300
Apr 20215600
May 20211500
Jun 2021100
Jul 2021622
Aug 2021200
Sep 2021600
Oct 20216403
Nov 20214800
Dec 20213510
Jan 20224130
Feb 20227500
Mar 20229300
Apr 20226900
May 20226000
Jun 20224710
Jul 20223110
Aug 20227320
Sep 20226200
Oct 202211413
Nov 20227010
Dec 20224001
Jan 20234100
Feb 20236000
Mar 20236300
Apr 20234011
May 20232600
Jun 20232200
Jul 20231800
Aug 20237400
Sep 20232410
Oct 20232400
Nov 20235110
Dec 20234821
Jan 20242000
Feb 20249100
Mar 20246311
Total76688792